| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1110062660 |
| P356 | DOI | 10.1186/S12882-018-1132-X |
| P932 | PMC publication ID | 6247501 |
| P698 | PubMed publication ID | 30458703 |
| P50 | author | Hélène François | Q73850020 |
| Romain Arrestier | Q93244283 | ||
| P2093 | author name string | Shao-Yu Zhang | |
| Isabelle Brocheriou | |||
| Vincent Audard | |||
| Emmanuelle Plaisier | |||
| Corinne Isnard-Bagnis | |||
| Anne-Pascale Satie | |||
| Nathalie Dejucq-Rainsford | |||
| Anissa Moktefi | |||
| Quentin Raimbourg | |||
| Marie Matignon | |||
| Guillaume Canaud | |||
| Philippe Gatault | |||
| Anne-Elisabeth Heng | |||
| Dil Sahali | |||
| David Buob | |||
| Flavia Vocila | |||
| P2860 | cites work | Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial. | Q50664664 |
| Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection | Q74111073 | ||
| Minimal-change nephropathy and chronic hepatitis C infection: coincidental or associated? | Q79517936 | ||
| Rituximab is an efficient and safe treatment in adults with steroid-dependent minimal change disease | Q85906649 | ||
| APOL1 risk genotype in European steroid-resistant nephrotic syndrome and/or focal segmental glomerulosclerosis patients of different African ancestries | Q89542423 | ||
| Nef stimulates proliferation of glomerular podocytes through activation of Src-dependent Stat3 and MAPK1,2 pathways | Q24563306 | ||
| Occurrence of minimal change nephrotic syndrome in classical Hodgkin lymphoma is closely related to the induction of c-mip in Hodgkin-Reed Sternberg cells and podocytes | Q24630620 | ||
| Truncation of C-mip (Tc-mip), a new proximal signaling protein, induces c-maf Th2 transcription factor and cytoskeleton reorganization | Q24673065 | ||
| Advances in the pathogenesis of HIV-associated kidney diseases | Q33415306 | ||
| c-mip impairs podocyte proximal signaling and induces heavy proteinuria | Q33965018 | ||
| Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities. | Q34135543 | ||
| APOL1 risk variants predict histopathology and progression to ESRD in HIV-related kidney disease | Q35715828 | ||
| Renal and thymic pathology in thymoma-associated nephropathy: report of 21 cases and review of the literature | Q36078916 | ||
| Minimal change nephrotic syndrome associated with non-Hodgkin lymphoid disorders: a retrospective study of 18 cases | Q36150869 | ||
| APOL1 Risk Variants Are Strongly Associated with HIV-Associated Nephropathy in Black South Africans | Q36223249 | ||
| Adult minimal-change disease: clinical characteristics, treatment, and outcomes. | Q36910586 | ||
| Reduction of Stat3 activity attenuates HIV-induced kidney injury | Q37367728 | ||
| The kidney as a reservoir for HIV-1 after renal transplantation | Q37524140 | ||
| Upregulation of c-mip is closely related to podocyte dysfunction in membranous nephropathy | Q37590239 | ||
| Immunopathogenesis of idiopathic nephrotic syndrome with relapse | Q37742644 | ||
| Clinical use of rituximab in patients with HIV related lymphoma and Multicentric Castleman's disease | Q37948889 | ||
| The treatment of minimal change disease in adults | Q38083643 | ||
| HIV-associated nephropathies: epidemiology, pathology, mechanisms and treatment | Q38357279 | ||
| HIV-associated immune complex kidney disease | Q38702034 | ||
| HIV-associated kidney glomerular diseases: changes with time and HAART. | Q39171965 | ||
| Rituximab for immunologic renal disease: What the nephrologist needs to know | Q39245887 | ||
| c-mip down-regulates NF-κB activity and promotes apoptosis in podocytes | Q39363968 | ||
| The Clinical Course of Minimal Change Nephrotic Syndrome With Onset in Adulthood or Late Adolescence: A Case Series | Q40380232 | ||
| Is there an association of hepatitis B virus infection with minimal change disease of nephrotic syndrome? A clinical observational report | Q41546573 | ||
| Prevalence of herpesviruses at onset of idiopathic nephrotic syndrome | Q42214478 | ||
| Glomerular disease and human immunodeficiency virus infection in Brazil | Q45118993 | ||
| Kidney Diseases Associated with Human Immunodeficiency Virus Infection | Q47297905 | ||
| NEPHRUTIX: A randomized, double-blind, placebo vs Rituximab-controlled trial assessing T-cell subset changes in Minimal Change Nephrotic Syndrome. | Q50065274 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nephrotic syndrome | Q504790 |
| P304 | page(s) | 331 | |
| P577 | publication date | 2018-11-20 | |
| P1433 | published in | BMC Nephrology | Q15750891 |
| P1476 | title | Minimal change nephrotic syndrome in patients infected with human immunodeficiency virus: a retrospective study of 8 cases | |
| P478 | volume | 19 |
Search more.